Non-invasive molecular imaging of vulnerable atherosclerotic plaques

Journal of Cardiology

Volumn 65, Issue 4, 2015, Pages 261-269

  Magnoni, Marco ^a,b   Ammirati, Enrico ^a,c   Camici, Paolo G ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Heart Care Foundation   (Italy)

^c Center of Cognitive Neuropsychology   (Italy)

Author keywords

Atherosclerosis; Computed tomography; Contrast enhanced ultrasound; Magnetic resonance imaging; Positron emission tomography; Vasa vasorum

Indexed keywords

ATHEROSCLEROTIC PLAQUE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; DISEASE SEVERITY; ECHOGRAPHY; HIGH RISK PATIENT; HUMAN; MOLECULAR IMAGING; NEOVASCULARIZATION (PATHOLOGY); NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT IDENTIFICATION; PREMATURITY; REVIEW; ATHEROSCLEROSIS; DIAGNOSTIC USE; PLAQUE, ATHEROSCLEROTIC; PROCEDURES;

CONTRAST MEDIUM;

ATHEROSCLEROSIS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; PLAQUE, ATHEROSCLEROTIC;

EID: 84927061237     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2015.01.004     Document Type: Review

References (64)

1. Maseri A. Ischemic heart disease: a rational basis for clinical practice and clinical research 1995, 323-335. Churchill Livingstone, New York.
2. de Vreede-Swagemakers J.J., Gorgels A.P., Dubois-Arbouw W.I., van Ree J.W., Daemen M.J., Houben L.G., Wellens H.J. Out-of-hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997, 30:1500-1505.
3. Hackett D., Verwilghen J., Davies G., Maseri A. Coronary stenoses before and after acute myocardial infarction. Am J Cardiol 1989, 63:1517-1528.
4. Ambrose J.A., Tannenbaum M.A., Alexopoulos D., Hjemdahl-Monsen C.E., Leavy J., Weiss M., Borrico S., Gorlin R., Fuster V. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988, 12:56-62.
5. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340:14-22.
6. Oudkerk M., Stillman A.E., Halliburton S.S., Kalender W.A., Möhlenkamp S., McCollough C.H., Vliegenthart R., Shaw L.J., Stanford W., Taylor A.J., van Ooijen P.M., Wexler L., Raggi P., European Society of Cardiac Radiology, North American Society for Cardiovascular Imaging Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Eur Radiol 2008, 18:2785-2807.
7. Grewal J., Anand S., Islam S., Lonn E., SHARE and SHARE-AP Investigators Prevalence and predictors of subclinical atherosclerosis among asymptomatic "low risk" individuals in a multiethnic population. Atherosclerosis 2008, 197:435-442.
8. Kathiresan S., Larson M.G., Keyes M.J., Polak J.F., Wolf P.A., D'Agostino R.B., Jaffer F.A., Clouse M.E., Levy D., Manning W.J., O'Donnell C.J. Assessment by cardiovascular magnetic resonance, electron beam computed tomography, and carotid ultrasonography of the distribution of subclinical atherosclerosis across Framingham risk strata. Am J Cardiol 2007, 99:310-314.
9. Falk E., Nakano M., Bentzon J.F., Finn A.V., Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur Heart J 2013, 34:719-728.
10. Spence J.D., Hegele R.A. Noninvasive phenotypes of atherosclerosis: similar windows but different views. Stroke 2004, 35:649-653.
11. Ammirati E., Magnoni M., Camici P.G. Need for new non-invasive imaging strategies to identify high-risk asymptomatic patients with carotid stenosis. Int J Cardiol 2013, 168:4342-4343.
12. Camici P.G., Rimoldi O.E., Gaemperli O., Libby P. Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque. Eur Heart J 2012, 33:1309-1317.
13. de Boer O.J., van der Wal A.C., Teeling P., Becker A.E. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?. Cardiovasc Res 1999, 41:443-449.
14. Kolodgie F.D., Gold H.K., Burke A.P., Fowler D.R., Kruth H.S., Weber D.K., Farb A., Guerrero L.J., Hayase M., Kutys R., Narula J., Finn A.V., Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003, 349:2316-2325.
15. Moreno P.R., Purushothaman K.R., Sirol M., Levy A.P., Fuster V. Neovascularization in human atherosclerosis. Circulation 2006, 113:2245-2252.
16. Barger A.C., Beeuwkes R., Lainey L.L., Silverman K.J. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984, 310:175-177.
17. Kumamoto M., Nakashima Y., Sueishi K. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 1995, 26:450-456.
18. Zhang Y., Cliff W.J., Schoefl G.I., Higgins G. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am J Pathol 1993, 143:164-172.
19. Kaufmann B.A., Sanders J.M., Davis C., Xie A., Aldred P., Sarembock I.J., Lindner J.R. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 2007, 116:276-284.
20. Khanicheh E., Mitterhuber M., Xu L., Haeuselmann S.P., Kuster G.M., Kaufmann B.A. Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis. PLoS One 2013, 8:e58761.
21. Feinstein S.B. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol 2004, 287:H450-H457.
22. Granada J.F., Feinstein S.B. Imaging of the vasa vasorum. Nat Clin Pract Cardiovasc Med 2008, 5(Suppl. 2):S18-S25.
23. Staub D., Schinkel A.F., Coll B., Coli S., van der Steen A.F., Reed J.D., Krueger C., Thomenius K.E., Adam D., Sijbrands E.J., ten Cate F.J., Feinstein S.B. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging 2010, 3:761-771.
24. Magnoni M., Coli S., Marrocco-Trischitta M.M., Melisurgo G., De Dominicis D., Cianflone D., Chiesa R., Feinstein S.B., Maseri A. Contrast-enhanced ultrasound imaging of periadventitial vasa vasorum in human carotid arteries. Eur J Echocardiogr 2009, 10:260-264.
25. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003, 9:653-660.
26. Coli S., Magnoni M., Sangiorgi G., Marrocco-Trischitta M.M., Melisurgo G., Mauriello A., Spagnoli L., Chiesa R., Cianflone D., Maseri A. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol 2008, 52:223-230.
27. Hjelmgren O., Johansson L., Prahl U., Schmidt C., Fredén-Lindqvist J., Bergström G.M. A study of plaque vascularization and inflammation using quantitative contrast-enhanced US and PET/CT. Eur J Radiol 2014, 83:1184-1189.
28. Staub D., Patel M.B., Tibrewala A., Ludden D., Johnson M., Espinosa P., Coll B., Jaeger K.A., Feinstein S.B. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke 2010, 41:41-47.
29. Deyama J., Nakamura T., Takishima I., Fujioka D., Kawabata K., Obata J.E., Watanabe K., Watanabe Y., Saito Y., Mishina H., Kugiyama K. Contrast-enhanced ultrasound imaging of carotid plaque neovascularization is useful for identifying high-risk patients with coronary artery disease. Circ J 2013, 77:1499-1507.
30. Magnoni M., Dagna L., Coli S., Cianflone D., Sabbadini M.G., Maseri A. Assessment of Takayasu arteritis activity by carotid contrast-enhanced ultrasound. Circ Cardiovasc Imaging 2011, 4:e1-e2.
31. Giordana P., Baqué-Juston M.C., Jeandel P.Y., Mondot L., Hirlemann J., Padovani B., Raffaelli C. Contrast-enhanced ultrasound of carotid artery wall in Takayasu disease: first evidence of application in diagnosis and monitoring of response to treatment. Circulation 2011, 124:245-247.
32. Schinkel A.F., van den Oord S.C., van der Steen A.F., van Laar J.A., Sijbrands E.J. Utility of contrast-enhanced ultrasound for the assessment of the carotid artery wall in patients with Takayasu or giant cell arteritis. Eur Heart J Cardiovasc Imaging 2014, 15:541-546.
33. 18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002, 105:2708-2711.
34. 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006, 48:1818-1824.
35. Rudd J.H., Myers K.S., Bansilal S., Machac J., Rafique A., Farkouh M., Fuster V., Fayad Z.A. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007, 50:892-896.
36. Tahara N., Kai H., Ishibashi M., Nakaura H., Kaida H., Baba K., Hayabuchi N., Imaizumi T. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006, 48:1825-1831.
37. Folco E.J., Sheikine Y., Rocha V.Z., Christen T., Shvartz E., Sukhova G.K., Di Carli M.F., Libby P. Hypoxia but not inflammation augments glucose uptake in human macrophages. Implications for imaging atherosclerosis with FdG-PET. J Am Coll Cardiol 2011, 58:603-614.
38. 11C]-PK11195 and positron emission tomography/computed tomography angiography. J Am Coll Cardiol 2010, 56:653-661.
39. 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J 2012, 33:1902-1910.
40. Hatsukami T.S., Yuan C. MRI in the early identification and classification of high-risk atherosclerotic carotid plaques. Imaging Med 2010, 2:63-75.
41. van den Bouwhuijsen Q.J., Vernooij M.W., Hofman A., Krestin G.P., van der Lugt A., Witteman J.C. Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study. Eur Heart J 2012, 33:221-229.
42. Kerwin W.S. Noninvasive imaging of plaque inflammation: role of contrast-enhanced MRI. J Am Coll Cardiol Imaging 2010, 3:1136-1138.
43. Sadat U., Teng Z., Young V.E., Graves M.J., Gaunt M.E., Gillard J.H. High-resolution magnetic resonance imaging-based biomechanical stress analysis of carotid atheroma: a comparison of single transient ischaemic attack, recurrent transient ischaemic attacks, non-disabling stroke and asymptomatic patient groups. Eur J Vasc Endovasc Surg 2011, 41:83-90.
44. Mitsumori L.M., Hatsukami T.S., Ferguson M.S., Kerwin W.S., Cai J., Yuan C. In vivo accuracy of multisequence MR imaging for identifying unstable fibrous caps in advanced human carotid plaques. J Magn Reson Imaging 2003, 17:410-420.
45. Yuan C., Mitsumori L.M., Ferguson M.S., Polissar N.L., Echelard D., Ortiz G., Small R., Davies J.W., Kerwin W.S., Hatsukami T.S. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001, 104:2051-2056.
46. Demarco J.K., Ota H., Underhill H.R., Zhu D.C., Reeves M.J., Potchen M.J., Majid A., Collar A., Talsma J.A., Potru S., Oikawa M., Dong L., Zhao X., Yarnykh V.L., Yuan C. MR carotid plaque imaging and contrast-enhanced MR angiography identifies lesions associated with recent ipsilateral thromboembolic symptoms: an in vivo study at 3T. AJNR Am J Neuroradiol 2010, 31:1395-1402.
47. Takaya N., Yuan C., Chu B., Saam T., Underhill H., Cai J., Tran N., Polissar N.L., Isaac C., Ferguson M.S., Garden G.A., Cramer S.C., Maravilla K.R., Hashimoto B., Hatsukami T.S. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke 2006, 37:818-823.
48. Trivedi R.A., Mallawarachi C., U-King-Im J.M., Graves M.J., Horsley J., Goddard M.J., Brown A., Wang L., Kirkpatrick P.J., Brown J., Gillard J.H. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 2006, 26:1601-1606.
49. Chu B., Ferguson M.S., Chen H., Hippe D.S., Kerwin W.S., Canton G., Yuan C., Hatsukami T.S. Magnetic resonance imaging features of the disruption-prone and the disrupted carotid plaque. J Am Coll Cardiol Imaging 2009, 2:883-896.
50. Tang T.Y., Howarth S.P., Miller S.R., Graves M.J., Patterson A.J., U-King-Im J.M., Li Z.Y., Walsh S.R., Brown A.P., Kirkpatrick P.J., Warburton E.A., Hayes P.D., Varty K., Boyle J.R., Gaunt M.E., et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009, 53:2039-2050.
51. Degnan A.J., Patterson A.J., Tang T.Y., Howarth S.P., Gillard J.H. Evaluation of ultrasmall superparamagnetic iron oxide-enhanced MRI of carotid atherosclerosis to assess risk of cerebrovascular and cardiovascular events: follow-up of the ATHEROMA trial. Cerebrovasc Dis 2012, 34:169-173.
52. Winter P.M., Morawski A.M., Caruthers S.D., Fuhrhop R.W., Zhang H., Williams T.A., Allen J.S., Lacy E.K., Robertson J.D., Lanza G.M., Wickline S.A. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003, 108:2270-2274.
53. Kerwin W., Hooker A., Spilker M., Vicini P., Ferguson M., Hatsukami T., Yuan C. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003, 107:851-856.
54. Pundziute G., Schuijf J.D., Jukema J.W., Decramer I., Sarno G., Vanhoenacker P.K., Reiber J.H., Schalij M.J., Wijns W., Bax J.J. Head-to-head comparison of coronary plaque evaluation between multislice computed tomography and intravascular ultrasound radiofrequency data analysis. J Am Coll Cardiol Interv 2008, 1:176-182.
55. Maurovich-Horvat P., Schlett C.L., Alkadhi H., Nakano M., Otsuka F., Stolzmann P., Scheffel H., Ferencik M., Kriegel M.F., Seifarth H., Virmani R., Hoffmann U. The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography. JACC Cardiovasc Imaging 2012, 5:1243-1252.
56. Kashiwagi M., Tanaka A., Kitabata H., Tsujioka H., Kataiwa H., Komukai K., Tanimoto T., Takemoto K., Takarada S., Kubo T., Hirata K., Nakamura N., Mizukoshi M., Imanishi T., Akasaka T. Feasibility of noninvasive assessment of thin-cap fibroatheroma by multidetector computed tomography. J Am Coll Cardiol Imaging 2009, 2:1412-1419.
57. Voros S., Rinehart S., Qian Z., Joshi P., Vazquez G., Fischer C., Belur P., Hulten E., Villines T.C. Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. J Am Coll Cardiol Imaging 2011, 4:537-548.
58. Hoffmann U., Moselewski F., Nieman K., Jang I.K., Ferencik M., Rahman A.M., Cury R.C., Abbara S., Joneidi-Jafari H., Achenbach S., Brady T.J. Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J Am Coll Cardiol 2006, 47:1655-1662.
59. Motoyama S., Kondo T., Sarai M., Sugiura A., Harigaya H., Sato T., Inoue K., Okumura M., Ishii J., Anno H., Virmani R., Ozaki Y., Hishida H., Narula J. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 2007, 50:319-326.
60. Motoyama S., Sarai M., Harigaya H., Anno H., Inoue K., Hara T., Naruse H., Ishii J., Hishida H., Wong N.D., Virmani R., Kondo T., Ozaki Y., Narula J. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009, 54:49-57.
61. Hyafil F., Cornily J.C., Feig J.E., Gordon R., Vucic E., Amirbekian V., Fisher E.A., Fuster V., Feldman L.J., Fayad Z.A. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 2007, 13:636-641.
62. 18F-FDG PET/CT and histology. J Nucl Med 2009, 50:959-965.
63. Cormode D.P., Roessl E., Thran A., Skajaa T., Gordon R.E., Schlomka J.P., Fuster V., Fisher E.A., Mulder W.J., Proksa R., Fayad Z.A. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology 2010, 256:774-782.
64. Romero J.M., Pizzolato R., Atkinson W., Meader A., Jaimes C., Lamuraglia G., Jaff M.R., Buonanno F., Delgado Almandoz J., Gonzalez R.G. Vasa vasorum enhancement on computerized tomographic angiography correlates with symptomatic patients with 50% to 70% carotid artery stenosis. Stroke 2013, 44:3344-3349.